Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

PARP inhibitors modulate upregulation of uPA gene expression in transformed endothelial cells

R. Caldini, L. Ciarpallini, M. Del Rosso, E. Barletta, M. Chevanne

Med Sci Monit 2003; 9(1): 6-0 :: ID: 14991

Abstract

Tumor growth and metastasis are complex processes which involve cell adhesion, proteolytic degradation of extracellular matrix and basement membrane, and cell migration. Several studies have demonstrated a pivotal role of the urokinase-type plasminogen activator (uPA) system in tumor growth, angiogenesis, and metastasis. In fact uPA and uPA receptor (uPAR) are overexpressed by many tumors and their expression correlates with tumor progression and poor prognosis, while downregulation of uPA or uPAR reduces invasiveness and tumorigenesis. In this study we demonstrate that FGF2 upregulation of uPA gene expression is mediated by poly(ADP-ribose) polymerase(PARP) activity. In fact. A specific inhibitor of PARP activity such as 3-aminobenzamide, as well as NAD+ deprivation, prevents FGF2-mediated uPA gene upregulation and cell-associated uPA production in transformed foetal bovine aortic endothelial cells GM7373. We also provide evidence that FGF2 enhances PARP activity by MAPK-dependent phosphorylation. It is noteworthy that also uPA-uPAR interaction controls uPA production through MAPK-dependent activation.Identification of the pathway which modulates upregulation of uPA gene expression, following MAPK activation, may be a new therapeutic target in anticancer therapy. In particular drugs which inhibit PARP activity could be relevant in the control of tumor angiogenesis and metastasis.

Keywords: PARP, uPA, FGF2, MAPK, GM7373 cells

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750